Cas no 130812-69-0 (D-chiro-Inositol, O-b-D-glucopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-)

D-chiro-Inositol, O-b-D-glucopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]- structure
130812-69-0 structure
Product Name:D-chiro-Inositol, O-b-D-glucopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
CAS No:130812-69-0
MF:C26H45NO18
MW:659.631410360336
CID:154208
PubChem ID:3083161
Update Time:2025-04-19

D-chiro-Inositol, O-b-D-glucopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]- Chemical and Physical Properties

Names and Identifiers

    • 2-[[6-[2,3-dihydroxy-6-(hydroxymethyl)-4-[[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
    • Validamycin H
    • 2,3-dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl 6-O-hexopyranosylhexopyranoside
    • 4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
    • 6)-O-b-D-glucopyranosyl-(1&reg
    • D-chiro-Inositol, O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosy l-(1-4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydro xymethyl)-2-cyclohexen-1-yl)amino)-, (1S-(1alpha,4alpha,5beta,6alpha)) -
    • D-chiro-Inositol, O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-, (1S-(1alpha,4alpha,5beta,6alpha))-
    • DTXSID30926921
    • 6''-O-beta-Glucopyranosylvalidamycin A
    • 130812-69-0
    • 12650-72-5
    • SCHEMBL5158901
    • D-chiro-Inositol, O-b-D-glucopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
    • Inchi: 1S/C26H45NO18/c28-3-7-1-9(14(32)18(36)13(7)31)27-10-2-8(4-29)24(21(39)15(10)33)45-26-23(41)20(38)17(35)12(44-26)6-42-25-22(40)19(37)16(34)11(5-30)43-25/h1,8-41H,2-6H2
    • InChI Key: FSQHOQRBXQDUST-UHFFFAOYSA-N
    • SMILES: O(C1C(C(C(C(COC2C(C(C(C(CO)O2)O)O)O)O1)O)O)O)C1C(C(C(CC1CO)NC1C=C(CO)C(C(C1O)O)O)O)O

Computed Properties

  • Exact Mass: 659.26365
  • Monoisotopic Mass: 659.264
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 15
  • Hydrogen Bond Acceptor Count: 19
  • Heavy Atom Count: 45
  • Rotatable Bond Count: 10
  • Complexity: 978
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 19
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: -8.4
  • Topological Polar Surface Area: 332?2

Experimental Properties

  • Density: 1.74
  • Boiling Point: 981.4°Cat760mmHg
  • Flash Point: 547.3°C
  • Refractive Index: 1.699
  • PSA: 332.17

130812-69-0 (D-chiro-Inositol, O-b-D-glucopyranosyl-(1®6)-O-b-D-glucopyranosyl-(1®4)-1,5,6-trideoxy-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-) Related Products

Recommended suppliers
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.